Michael E. McManus - Concepedia

Author

Michael E. McManus

Also Known As

M E McManus, M McManus, M. E. McManus, M. E. Mcmanus, M. McManus, M.E McManus, M.E. McManus, M.E. Mcmanus, ME McManus, McManus M

166

Publications

6.3K

Citations

H-Index

105

Concepts

All Affiliations

Flinders University The University of Queensland Flinders Medical Centre National Cancer Institute Lawrence Livermore National Laboratory

About

Michael E. McManus is an author at Flinders University specializing in biochemistry, pharmacology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	36	2K
2	Natural Sciences	14	19	734
3	Health Sciences	10	11	720
4	Engineering	2	2	42
5	Education	1	1	11

Michael E. McManus

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. Wichittra Tassaneeyakul, Donald Birkett, M Veronese, Journal of Pharmacology and Experimental Therapeutics	1993	317
Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. Michael E. McManus, Wendy Burgess, M Veronese, PubMed P450ia2 ProteinsBiochemistryToxicological MechanismMedicineMetabolomic Profiling	1990	288
N- and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells Rodney F. Minchin, P.T. Reeves, Candee H. Teitel, Biochemical and Biophysical Research Communications Cos-1 CellsCombinatorial ChemistryHeterocyclicBiochemistryOrganic Chemistry	1992	248
Effects of age and gender on in vitro properties of human liver microsomal monooxygenases Douglas L. Schmucker, K.W. Woodhouse, Rose K. Wang, Clinical Pharmacology & Therapeutics	1990	208
Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9 Maurice E. Veronese, Peter I. Mackenzie, Christopher J Doecke, Biochemical and Biophysical Research Communications Molecular PharmacologyBiochemistryMedicineLiver PhysiologyHepatotoxicity	1991	206
Tolbutamide hydroxylation by human liver microsomes John O. Miners, Kerry J. Smith, Richard A. Robson, Biochemical Pharmacology HepatologyBiochemistryTolbutamide HydroxylationLiver PhysiologyMedicine	1988	200
Caffeine metabolism by human hepatic cytochromes p450: Contributions of 1A2, 2E1 and 3A isoforms Wichittra Tassaneeyakul, Donald J. Birkett, Michael E. McManus, Biochemical Pharmacology Molecular PharmacologyEnergy MetabolismBiochemistryMedicineLiver Physiology	1994	199
Structure of a Human Carcinogen-converting Enzyme, SULT1A1 Niranjali Gamage, Ronald G. Duggleby, Amanda C. Barnett, Journal of Biological Chemistry	2003	167
Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues. Ross A. McKinnon, W M Burgess, Pauline Hall, Gut Molecular PhysiologyHuman Cyp3a SubfamilyGastrointestinal PharmacologyLiver PhysiologyImmunology	1995	157
Site-directed mutation studies of human liver cytochrome <i>P</i>-450 isoenzymes in the CYP2C subfamily M Veronese, C. J. Doecke, Peter I. Mackenzie, Biochemical Journal	1993	131

Page 1